23 filings
8-K
NBY
Novabay Pharmaceuticals Inc
20 Dec 19
Departure of Directors or Certain Officers
4:15pm
8-K
NBY
Novabay Pharmaceuticals Inc
10 Oct 19
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
NBY
Novabay Pharmaceuticals Inc
16 Sep 19
NovaBay Pharmaceuticals Names Finance Executive Jeff Zheng to its Board of Directors
4:30pm
8-K
NBY
Novabay Pharmaceuticals Inc
13 Aug 19
Amendments to Articles of Incorporation or Bylaws
4:30pm
8-K
NBY
Novabay Pharmaceuticals Inc
9 Aug 19
NovaBay Pharmaceuticals Announces Pricing of $4.2 Million Registered Direct Offering
9:02am
8-K
9ckjod3c 3vpc
7 Aug 19
NovaBay Pharmaceuticals Reports 2019 Second Quarter Financial Results
8:00am
8-K
cm5e1l j6d0tvrk5
29 Jul 19
NovaBay Pharmaceuticals Reports 2019 Second Quarter Net Sales of $1.8 Million
8:30am
8-K
udac8c v82jiv
25 Jul 19
Departure of Directors or Certain Officers
4:30pm
8-K
tx4 y2a2l
15 Jul 19
NovaBay Pharmaceuticals Issues Letter to Stockholders
8:30am
8-K
pu16ad4ponq
1 Jul 19
Other Events
8:32am
8-K
fu6azywioklf6z3gf6
26 Jun 19
Entry into a Material Definitive Agreement
4:31pm
8-K
dbsym9xa1xfhqg
19 Jun 19
Entry into a Material Definitive Agreement
8:30am
8-K
fi1 mvfcyy
17 Jun 19
NovaBay Pharmaceuticals Appoints Justin Hall President and CEO, and Jason Raleigh CFO
8:31am
8-K
qsjxj9 sndpdhq
3 Jun 19
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
4237au xdjxb7
21 May 19
NovaBay Pharmaceuticals Receives NYSE American Communication
4:50pm
8-K
4k02sve8kyox5
13 May 19
NovaBay Pharmaceuticals Reports First Quarter 2019 Financial Results
4:30pm
8-K
u8v 47wqwjz
3 May 19
Departure of Directors or Certain Officers
4:30pm
8-K
ht2ww43zpc9t2m
15 Apr 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
kakq g13y7dukripo
1 Apr 19
NovaBay Pharmaceuticals Announces Investments of $5 Million to Support U.S. Avenova Commercialization Strategy
9:17am
8-K
xjx2c2ssrz slgi
28 Mar 19
Entry into a Material Definitive Agreement
8:45am